BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35436029)

  • 21.
    Wang D; He S; Liu B; Liu C
    Clin Sci (Lond); 2018 May; 132(9):943-958. PubMed ID: 29572385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of the macrophage-hepatic stellate cell interaction by targeting macrophage peroxisome proliferator-activated receptor gamma to prevent non-alcoholic steatohepatitis progression in mice.
    Ni XX; Ji PX; Chen YX; Li XY; Sheng L; Lian M; Guo CJ; Hua J
    Liver Int; 2022 Dec; 42(12):2696-2712. PubMed ID: 36165186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Crucial Role of PPARγ-Egr-1-Pro-Inflammatory Mediators Axis in IgG Immune Complex-Induced Acute Lung Injury.
    Yan C; Chen J; Ding Y; Zhou Z; Li B; Deng C; Yuan D; Zhang Q; Wang X
    Front Immunol; 2021; 12():634889. PubMed ID: 33717177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
    Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities.
    Makowski L; Brittingham KC; Reynolds JM; Suttles J; Hotamisligil GS
    J Biol Chem; 2005 Apr; 280(13):12888-95. PubMed ID: 15684432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptidoglycan induced expression of peroxisome proliferator-activated receptor γ in mouse peritoneal macrophages: role of ERK and JNK MAP kinases.
    Bhatt KH; Sodhi A; Chakraborty R
    Cytokine; 2012 Dec; 60(3):778-86. PubMed ID: 22925536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pioglitazone Increases Blood-Brain Barrier Expression of Fatty Acid-Binding Protein 5 and Docosahexaenoic Acid Trafficking into the Brain.
    Low YL; Jin L; Morris ER; Pan Y; Nicolazzo JA
    Mol Pharm; 2020 Mar; 17(3):873-884. PubMed ID: 31944767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitrated Fatty Acids Reverse Cigarette Smoke-Induced Alveolar Macrophage Activation and Inhibit Protease Activity via Electrophilic S-Alkylation.
    Reddy AT; Lakshmi SP; Muchumarri RR; Reddy RC
    PLoS One; 2016; 11(4):e0153336. PubMed ID: 27119365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
    Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
    J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Senescence Alters PPARγ (Peroxisome Proliferator-Activated Receptor Gamma)-Dependent Fatty Acid Handling in Human Adipose Tissue Microvascular Endothelial Cells and Favors Inflammation.
    Briot A; Decaunes P; Volat F; Belles C; Coupaye M; Ledoux S; Bouloumié A
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1134-1146. PubMed ID: 29545239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tamoxifen inhibits macrophage FABP4 expression through the combined effects of the GR and PPARγ pathways.
    Jiang M; Zhang L; Ma X; Hu W; Chen Y; Yu M; Wang Q; Li X; Yin Z; Zhu Y; Gao X; Hajjar DP; Duan Y; Han J
    Biochem J; 2013 Sep; 454(3):467-77. PubMed ID: 23805908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD.
    Lea S; Plumb J; Metcalfe H; Spicer D; Woodman P; Fox JC; Singh D
    Eur Respir J; 2014 Feb; 43(2):409-20. PubMed ID: 23794466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wutou decoction attenuates the synovial inflammation of collagen-induced arthritis rats via regulating macrophage M1/M2 type polarization.
    Lin W; Shen P; Huang Y; Han L; Ba X; Huang Y; Yan J; Li T; Xu L; Qin K; Chen Z; Tu S
    J Ethnopharmacol; 2023 Jan; 301():115802. PubMed ID: 36209953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages.
    Mayi TH; Duhem C; Copin C; Bouhlel MA; Rigamonti E; Pattou F; Staels B; Chinetti-Gbaguidi G
    FEBS J; 2010 Aug; 277(16):3308-20. PubMed ID: 20608974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein arginine methyltransferase 1 modulates innate immune responses through regulation of peroxisome proliferator-activated receptor γ-dependent macrophage differentiation.
    Tikhanovich I; Zhao J; Olson J; Adams A; Taylor R; Bridges B; Marshall L; Roberts B; Weinman SA
    J Biol Chem; 2017 Apr; 292(17):6882-6894. PubMed ID: 28330868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wogonin prevents lipopolysaccharide-induced acute lung injury and inflammation in mice via peroxisome proliferator-activated receptor gamma-mediated attenuation of the nuclear factor-kappaB pathway.
    Yao J; Pan D; Zhao Y; Zhao L; Sun J; Wang Y; You QD; Xi T; Guo QL; Lu N
    Immunology; 2014 Oct; 143(2):241-57. PubMed ID: 24766487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythromycin inhibits cigarette smoke-induced inflammation through regulating the PPARγ/NF-κB signaling pathway in macrophages.
    Qiu JF; Ma N; He ZY; Zhong XN; Zhang JQ; Bai J; Deng JM; Tang XJ; Luo ZL; Huang M; Liang Q; Wei YL; Tang MJ; Li MH
    Int Immunopharmacol; 2021 Jul; 96():107775. PubMed ID: 34162143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of FABP5 attenuates inflammatory bowel disease by modulating macrophage alternative activation.
    Xu J; Zheng B; Xie C; Zhao Y; Wu H; Wang Y; Guan X; Lei X; Liu D; Lou X; Chen X; Huang Y
    Biochem Pharmacol; 2024 Jan; 219():115974. PubMed ID: 38081366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic Analysis of Signaling Pathways Modulated by FABP5 in Macrophages.
    Doswell F; Haley JD; Kaczocha M
    J Pharmacol Exp Ther; 2024 Jun; ():. PubMed ID: 38849143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)γ-DEPENDENT MECHANISM.
    Yu M; Jiang M; Chen Y; Zhang S; Zhang W; Yang X; Li X; Li Y; Duan S; Han J; Duan Y
    J Biol Chem; 2016 Aug; 291(33):16977-89. PubMed ID: 27358406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.